Alogliptin (Nesina)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Alogliptin (Nesina), covering 2011-08-29 to 2011-08-29. Get the full timeline:
Most recent: Clinical Trial Update: Long-term Safety Study of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan [Phase 2, Phase 3]